WHO SMART Guidelines - Example Workshop IG
0.1.0 - ci-build
WHO SMART Guidelines - Example Workshop IG, published by WHO. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/brynrhodes/smart-workshop/ and changes regularly. See the Directory of published versions
| Official URL: http://id.who.int/icd/release/11/mms | Version: 0.1.0 | |||
| Draft as of 2024-12-02 | Computable Name: ICD11 | |||
ICD-11.
This Code system is referenced in the content logical definition of the following value sets:
Generated Narrative: CodeSystem ICD11
Properties
This code system defines the following properties for its concepts
| Name | Code | URI | Type |
| Parent | parent | http://hl7.org/fhir/concept-properties#parent | code |
Concepts
This case-sensitive code system http://id.who.int/icd/release/11/mms provides a fragment that includes following codes in a Is-A hierarchy:
| Lvl | Code | Display | Parent |
| 1 | XM28X5 | Measles vaccines | |
| 2 | XM8L15 | Measles, live attenuated | XM28X5 |
| 2 | XM9439 | Measles, combinations with mumps, live attenuated | XM28X5 |
| 2 | XM8TF3 | Measles, combinations with mumps and rubella, live attenuated | XM28X5 |
| 2 | XM21H2 | Measles, combinations with rubella, live attenuated | XM28X5 |
| 2 | XM4AJ8 | Measles, combinations with mumps, rubella and varicella, live attenuated | XM28X5 |
| 1 | XM1131 | Mumps vaccines | |
| 2 | XM2340 | Mumps, live attenuated | XM1131 |
| 1 | XX45B7 | Intersex | |
| 1 | XX2PX3 | Biological sex not specified | |
| 1 | XX2V25 | Female | |
| 1 | XX2UQ8 | Male | |
| 1 | 1B1Z | Tuberculosis | |
| 1 | 1C62.Z | Human immunodeficiency virus disease without mention of tuberculosis or malaria | |
| 1 | 1H0Z | Certain infectious or parasitic diseases | |
| 1 | 3A51 | Sickle cell disorders or other haemoglobinopathies | |
| 1 | 4B4Z | Diseases of the immune system | |
| 1 | KA21.4 | Preterm newborn | |
| 1 | QA02.0 | Observation for suspected tuberculosis, ruled out | |
| 1 | QA02.Y | Medical observation or evaluation for suspected diseases or conditions, ruled out | |
| 1 | QA48.1 | Care or examination of lactating mother | |
| 1 | QC60 | Family history of infectious diseases | |
| 1 | XM18Y8 | Meningococcus C, purified polysaccharides antigen conjugated vaccines | |
| 1 | XM2280 | Meningococcus A, purified polysaccharides antigen conjugated vaccines | |
| 1 | XM33K4 | Typhoid, oral, live attenuated vaccines | |
| 1 | XM3KQ4 | Interferon gamma | |
| 1 | XM3SF6 | Typhoid, purified polysaccharide antigen vaccines | |
| 1 | XM47S0 | Encephalitis, Japanese, live attenuated | |
| 1 | XM5V19 | Poliomyelitis, trivalent, inactivated, whole virus | |
| 1 | XM79H3 | Poliomyelitis oral, bivalent, live attenuated | |
| 1 | XM7PF6 | Tuberculin | |
| 1 | XT0S | Pregnancy | |
| 1 | QA41 | Pregnant state | |
| 1 | QC44.0 | Personal history of anaphylaxis | |
| 1 | QC44.2 | Personal history of allergy to drugs, medicaments or biological substances | |
| 1 | 1C62.1 | HIV disease clinical stage 2 without mention of tuberculosis or malaria | |
| 1 | MA14.0 | Laboratory evidence of human immunodeficiency virus | |
| 1 | XM8142 | Tuberculosis, live attenuated vaccines | |
| 1 | XM72A0 | Cholera, live attenuated vaccines | |
| 1 | XM0VX8 | Poliomyelitis oral, monovalent live attenuated | |
| 1 | XM0KZ1 | Poliomyelitis oral, trivalent, live attenuated | |
| 1 | XM4GV0 | Rota virus, live attenuated | |
| 1 | XM9PS9 | Rubella, live attenuated | |
| 1 | XM3B09 | Rubella, combinations with mumps, live attenuated | |
| 1 | XM5V64 | Influenza vaccines, live attenuated | |
| 1 | XM0NS8 | Varicella, live attenuated | |
| 1 | XM3418 | Yellow Fever, live attenuated | |
| 1 | XM5DF6 | COVID-19 vaccines, live attenuated virus |